Exhibit 99
Xxxxxxx X. Xxxxxxx is a Director, the Chairman and the Chief Executive Officer
of FMR LLC.
Members of the Xxxxxxx family, including Xxxxxxx X. Xxxxxxx, are the
predominant owners, directly or through trusts, of Series B voting common
shares of FMR LLC, representing 49% of the voting power of FMR LLC. The
Xxxxxxx family group and all other Series B shareholders have entered into a
shareholders' voting agreement under which all Series B voting common shares
will be voted in accordance with the majority vote of Series B voting common
shares. Accordingly, through their ownership of voting common shares and the
execution of the shareholders' voting agreement, members of the Xxxxxxx family
may be deemed, under the Investment Company Act of 1940, to form a controlling
group with respect to FMR LLC.
This filing reflects the securities beneficially owned, or that may be deemed
to be beneficially owned, by FMR LLC, certain of its subsidiaries and
affiliates, and other companies (collectively, the "FMR Reporters"). This
filing does not reflect securities, if any, beneficially owned by certain
other companies whose beneficial ownership of securities is disaggregated from
that of the FMR Reporters in accordance with Securities and Exchange
Commission Release No. 34-39538 (January 12, 1998).
RULE 13d-1(k)(1) AGREEMENT
The undersigned persons, on December 5, 2024, agree and consent to the joint
filing on their behalf of this Schedule 13G in connection with their
beneficial ownership of the COMMON STOCK of ONCOLOGY INSTITUTE INC/THE at
November 29, 2024.
FMR LLC
By /s/ Xxxxxxxxx X. Xxxxx
Xxxxxxxxx X. Xxxxx
Xxxx authorized under Power of Attorney effective as of January 3, 2023, by
and on behalf of FMR LLC and its direct and indirect subsidiaries*
Xxxxxxx X. Xxxxxxx
By /s/ Xxxxxxxxx X. Xxxxx
Xxxxxxxxx X. Xxxxx
Xxxx authorized under Power of Attorney effective as of January 26, 2023, by
and on behalf of Xxxxxxx X. Xxxxxxx**
* This power of attorney is incorporated herein by reference to Exhibit 24 to
the Schedule 13G filed by FMR LLC on January 10, 2023, accession number:
0000315066-23-000003.
** This power of attorney is incorporated herein by reference to Exhibit 24 to
the Schedule 13G filed by FMR LLC on January 31, 2023, accession number:
0000315066-23-000038.
